Compounds > oxybutynin
Page last updated: 2024-11-02

oxybutynin and Parotid Neoplasms

oxybutynin has been researched along with Parotid Neoplasms in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Parotid Neoplasms: Tumors or cancer of the PAROTID GLAND.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mantsopoulos, K1
Goncalves, M1
Iro, H1
Becelli, R1
Morello, R1
Renzi, G1
Matarazzo, G1

Trials

1 trial available for oxybutynin and Parotid Neoplasms

ArticleYear
Use of scopolamine patches in patients treated with parotidectomy.
    The Journal of craniofacial surgery, 2014, Volume: 25, Issue:1

    Topics: Adenoma, Pleomorphic; Combined Modality Therapy; Drainage; Humans; Parotid Gland; Parotid Neoplasms;

2014

Other Studies

1 other study available for oxybutynin and Parotid Neoplasms

ArticleYear
Transdermal scopolamine for the prevention of a salivary fistula after parotidectomy.
    The British journal of oral & maxillofacial surgery, 2018, Volume: 56, Issue:3

    Topics: Cholinergic Antagonists; Female; Humans; Male; Parotid Gland; Parotid Neoplasms; Retrospective Studi

2018